Fact: Stopping GLP-1 medications suddenly may contribute to increased appetite and rapid weight regain, so its important to work with a healthcare provider on a transition plan
the root, bark, and seeds contain additional compounds including moringine and moringinine that may be harmful in concentrated doses and should not be used without medical advice
Retatrutide is not licensed in the UK and is only available through approved clinical trials
These symptoms typically resolve as your body equilibrates to the medication, but persistent or severe chills warrant immediate contact with your prescribing provider
The information in this article is for educational and informational purposes only and does not constitute medical advice
A 2025 analysis found that GLP-1 agonists given for diabetes were associated with a reduced risk of substance use among hundreds of thousands of United States Veterans and a 2024 examination of over 500k patients 4 Qeadan, F., McCunn, A., & Tingey, B